0001209191-16-137770.txt : 20160818 0001209191-16-137770.hdr.sgml : 20160818 20160818162600 ACCESSION NUMBER: 0001209191-16-137770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160817 FILED AS OF DATE: 20160818 DATE AS OF CHANGE: 20160818 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 161841183 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-17 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2016-08-17 4 M 0 6500 36.30 A 274725 D Common Stock 2016-08-17 4 S 0 4000 99.36 D 270725 D Common Stock 2016-08-17 4 S 0 2500 99.99 D 268225 D Common Stock 13286 I 401k Common Stock 2016-08-17 4 S 0 400 100.03 D 80300 I Common Stock Held In Trust Stock Option (Right to Buy) 36.30 2016-08-17 4 M 0 6500 0.00 D 2017-01-23 Common Stock 6500 138000 D Transaction made pursuant to the holder's company approved trading plan under Rule 10b5-1. The holder undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $99.36 (range $98.87 to $99.84). Open market sales reported on this line occurred at a weighted average price of $99.99 (range $99.91 to $100.12). Open market sales reported on this line occurred at a weighted average price of $100.03 (range $100.00 to $100.08). Fully vested. Omar White, Attorney-In-Fact 2016-08-18